Low "good" cholesterol may flag breast cancer risk

Key points
- Among older overweight women, low levels of HDL ("good") cholesterol may signal an increased risk of breast cancer risk, research suggests.
- Anne-Sofie Furberg from the University of Tromso in Norway and colleagues studied nearly 39,000 Norwegian women who provided data on lipids, weight, diet, and lifestyle.
- As reported in the Journal of the National Cancer Institute, low HDL cholesterol was associated with an increased risk of breast cancer after menopause in overweight women.
- Furberg emphasized that "the observed association ... needs to be confirmed in studies of other populations to verify the role of HDL cholesterol as a useful maker."
Among older overweight women, low levels of HDL ("good") cholesterol may signal an increased risk of breast cancer risk, research suggests.
Dr. Anne-Sofie Furberg from the University of Tromso in Norway and colleagues studied nearly 39,000 Norwegian women who provided data on lipids, weight, diet, and lifestyle. They were followed for an average of 17 years, during which time a total of 708 women developed invasive breast cancer.
As reported in the Journal of the National Cancer Institute, low HDL cholesterol was associated with an increased risk of breast cancer after menopause in overweight women.
According to Furberg, "when the overweight and obese women were divided in four equalized subgroups according to increasing levels of HDL cholesterol in the blood, women with the lowest level of HDL cholesterol had a threefold higher risk of postmenopausal breast cancer as compared to women with the highest level of HDL cholesterol."
Furberg emphasized that "the observed association ... needs to be confirmed in studies of other populations to verify the role of HDL cholesterol as a useful maker."
SOURCE: Journal of the National Cancer Institute, August 4, 2004.
Written and revised by
David Cohen, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsNonrecommended screenings for prostate, breast cancer in older individuals
An estimated 15.7 percent of individuals 65 or older may have received nonrecommended screenings for prostate and breast cancers because they had limited life expectancies of less than 10 years, according to an article…
22 January 2016
GuideNew method for better treatment of breast cancer
A new study shows that a novel imaging-based method for defining appropriateness of breast cancer treatment is as accurate as the current standard-of-care and could reduce the need for invasive tissue sampling. The…
31 December 2015
NewsT cells that recognize HER2 teceptor may prevent HER2+ breast cancer recurrence
Recurrence of HER2-positive breast cancer after treatment may be due to a specific and possibly cancer-induced weakness in the patient's immune system - a weakness that in principle could be corrected with a…




